: Efficacy and Safety of Tofacitinib in Patients With Active Ankylosing Spondylitis (AS)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study of the Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)

Category & Conditions:
Immune System Diseases and Conditions
Medicine:
XELJANZ®(TOFACITINIB)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
A3921120
Open Plain Language Summary Result:Click here